Sanhome Pharmaceutical

Guided by the mission of blessing more people with enjoyment of good health, Sanhome makes great efforts to raise the technology content of the new and high-tech products. Committed ourselves to the scientific research and development of new products, Sanhome has got over 100 new drug certificates so far and has been awarded more than10 national patents and international patents. In the new drug research center established by the company, we have independently developed various kinds of Chinese Traditional Medicine and Western Medicine with the exclusive technology of our own, among which there are national 1st rank new drug, national key products, TMC under national protection, National Patent products. Sanhome have also borne the responsibility of conducting more than 20 scientific research projects including National 863 Projects, Projects of New Drug Discovery Initiative, National Innovation Fund and National Torch Program. The research and development of new products have been a substantial drive for the sustainable and vigorous development of the company. In 2001, the company was listed among the "Nanjing New and High-tech Enterprises" by Nanjing Science and Technology Bureau. In 2003 Sanhome was certified as "New and High-tech Enterprises of Jiangsu" by Science and Technology Government Agency of Jiangsu and was certified as national "Key New and High-tech Enterprises" by the Ministry of Science and Technology. In 2008 postdoctoral research workstation was approved to establish by the Ministry of Human Resources and Social Security. In recent years, provincial engineering technology research and development center, provincial enterprise technology center and national innovation medicine incubation base have been established in succession in Sanhome. Presently, Sanhome possesses various production lines which can produce tablets, granules, capsules, freeze-dried powder injection, powder injection, ointments, large volume injections, and small volume injections. More than 30 varieties are marketed nationwide. Our leading products including "ShengNuoAn", "ShengNuoLing", "Xiao Yanping" have endowed with the honorable title of "New and High-tech Product" by Jiangsu Province and Nanjing city. Sanhome has formed the characters of scientific and technological innovation by keeping on launching and producing new products with desirable therapeutic effects and broad market prospects. Sanhome has a marketing team with high professional knowledge, rich clinical experience, pioneering spirits who are full of vigor and enthusiasm. Sticking to the client-oriented principle, and thanks to the marketing net covering every part of the nation, Sanhome has gained trust and praise from its clients and patients with its high-quality products and excellent service. On August 13, 2009, S-Ornidazole and its agent, which is a new chemical drug with 5 national patents and 2 international patents, obtained the national 1st rank new drug certificate and production approval letter with the approval of SFDA. The company has spent nearly 10 years on the research of S-Ornidazole and input more than 300 million RMB in it since August 2008. As the research achievement of national "Projects of New Drug Discovery Initiative", it became the first chemical drug with the international patent protection. It will benefit the company with huge profit. Now S-Ornidazole has launched the registration for FDA and will promise to be approved. S-Ornidazole will be the first new chemical drug marketing in Europe and US. In recent years, our company carried out the strategy of entering international market after plenty of surveys and investigations for pharmaceutical industry in developing countries, such as the United States, Canada, and Europe. The strategy consists of two parts: attracting talents and research cooperation. So far, many scholars, doctors, and senior managers, who have studied and lived in Europe and America for many years and are experienced in drug research and marketing joined us. Sanhome (US) Pharmaceutical Co., Ltd. has been established in Maryland, America, which will accelerate the cooperation with pharmaceutical enterprises and research organizations abroad. Sanhome begins entering the international market with the series of strategies. Sanhome not only makes contribution to national pharmaceutical industry and economic development, but also devotes to philanthropy. It has made donations over millions of thousands yuan to "Nanjing Bright Foundation", "Poverty Alleviation and Assistance", "Project Hope", "SARS", "Subei Lianshui Poverty Alleviation", and "Sichuan Earthquake Relief Work". In November 2003, Wang Yong, CEO and General Manager, was awarded the title of "Bright Foundation Stars" and elected to be vice-chairman of the third "Nanjing Bright Foundation" promotion association. It is the best affirmation and encouragement for Sanhome. In order to improve the scientific and technological creativity and production capability, the company has already launched a series of projects, such as "Liuhe Bulk Drug Production Base", "Nanjing Qilin Technology Innovation Park and research centre", "Yunnan Jinping Traditional Chinese Medicinal Materials Planting Base" etc. In the seventeen years since it was founded, Sanhome formed its development path step by step. Sales increased continuously in a big margin. The core competitiveness of Sanhome is specialized in strong product creativity, broad market prospect, and large alternative drug reserve, which realized the excessive speed of development. According to the data of ETIRI, Sanhome has been ranked into top 100 pharmaceutical enterprises in 2011. Its comprehensive strength ranked No. 86 in 100 pharmaceutical enterprises and No. 8 in innovative enterprises. Its taxation and profits are better. It indicates that Sanhome has good development potential while making active contribution to pharmaceutical industry and economic development. In 2004, it was awarded the honorable title of "May 1st Work Certificate" by All China Federation of Trade Unions. Wang Yong, the CEO and General Manager was awarded the titles of "China May 4th Youth Medal", "Excellent Science and Technology Private Entrepreneur of China", "China Outstanding Achievement Award of Pharmacy", "Top 10 Outstanding Youth of Nanjing", """ Jiangsu Model Worker", "Jiangsu Young Expert with Outstanding Contribution ", "Jiangsu 333 Engineering Experts", "Science and Technology Award to Young People of Nanjing" , "Jiangsu Excellent Builder of Socialism with Chinese Characteristics", "Nanjing Top Ten Outstanding Youth", "Science and Technology Contributor of Nanjing", "Nanjing Outstanding Pioneer of Zijin Science and Technology ", "Outstanding Young Talent of Nanjing", "Nanjing Excellent Builder of Socialism with Chinese Characteristics" etc. Now Sanhome is trying every means to promote the national pharmaceutical industry with the feature of scientific and technological progress as its drive, new and high-tech as its support, excellent talent as its leading power. Sanhome insists on the developing strategy of "high tech, high speed and high efficiency" and will open up a new chapter for health of human beings.